| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 04/15/2003 | US6548486 New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid |
| 04/10/2003 | WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/10/2003 | US20030069423 Novel processes for the preparation of adenosine compounds and intermediates thereto |
| 04/10/2003 | US20030069259 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 04/10/2003 | US20030069257 Benzimidazole and pyridylimidazole derivatives |
| 04/09/2003 | EP1300147A1 Purine compounds and adenosine A2 receptor antagonist as preventive or therapeutic agent for diabetes mellitus |
| 04/09/2003 | CN1105109C Chloropyrimide intermediates |
| 04/08/2003 | US6545002 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy |
| 04/08/2003 | US6545001 Antiviral nucleoside analogues |
| 04/08/2003 | CA2086756C Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections |
| 04/03/2003 | WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 04/03/2003 | WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 04/03/2003 | WO2002076460A3 Use of propentofylline to control intraocular pressure |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/03/2003 | US20030064999 Therapy for asthma, diarrhea |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064374 Detecting neuronal stress in humans; obtain sample, measure phosphodiesterase concentration, evaluate for neuronal stress |
| 04/02/2003 | EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP0874846B1 Purine derivatives and processes for their preparation |
| 04/02/2003 | CN1406946A Technology for producing AR with IR as initiation material by liquid ammonia process |
| 04/01/2003 | US6541625 Stereoselectively hydrolyzing an anomeric mixture of 2-benzoyloxydioxolanecarboxylate with an enzyme; separating product; replacing carboxylate by reaction with a purine or pyrimidinyl derivative |
| 04/01/2003 | US6541482 Autoimmune disease |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2003024965A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 03/27/2003 | WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | US20030060627 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives |
| 03/27/2003 | US20030060476 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration |
| 03/27/2003 | US20030056712 Production method of famciclovir and production and crystallization method of intermediate therefor |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2460151A1 Cytokine receptor |
| 03/26/2003 | EP1294722A2 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 03/26/2003 | EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 03/26/2003 | EP1294362A1 Novel process for preparing crystalline particles |
| 03/26/2003 | EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors |
| 03/26/2003 | CN1103593C Synergistic composition |
| 03/20/2003 | WO2003022845A1 Pyrazolo-pyridines for the treatment of herpes infections |
| 03/20/2003 | WO2003022805A2 Heterocycle substituted purines as antiproliferative agents |
| 03/20/2003 | WO2003022284A1 Methods of treating pulmonary disease |
| 03/20/2003 | WO2003022274A2 2-aroylimidazole compounds for treating cancer |
| 03/20/2003 | WO2003022219A2 Biarylamino purine antiproliferative agents |
| 03/20/2003 | WO2003022216A2 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 03/20/2003 | WO2003022214A2 Piperazine and homopiperazine compounds |
| 03/20/2003 | WO2003022209A2 Crystalline forms of valacyclovir hydrochloride |
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2003 | US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient |
| 03/20/2003 | US20030055021 Compounds for the treatment of ischemia |
| 03/20/2003 | US20030054028 Sustained releasing drug in situ |
| 03/20/2003 | CA2460345A1 2-aroylimidazole compounds for treating cancer |
| 03/20/2003 | CA2459533A1 Methods of treating pulmonary disease |
| 03/20/2003 | CA2457835A1 Crystalline forms of valacyclovir hydrochloride |
| 03/19/2003 | EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/19/2003 | EP1292603A2 Methods and compositions for treating hepatitis c virus |
| 03/19/2003 | EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 03/19/2003 | CN1403457A Prepn process of 2,6-dichloropurine |
| 03/18/2003 | US6534651 Substituted isoindolinone derivatives |
| 03/18/2003 | US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection |
| 03/18/2003 | US6534512 Dideoxycarbocyclic nucleosides |
| 03/18/2003 | US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders |
| 03/13/2003 | WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 03/13/2003 | WO2003020281A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| 03/13/2003 | WO2002094740A3 Hydrogenation processes performed in ionic liquids |
| 03/13/2003 | WO2002088080A3 Dual inhibitors of pde 7 and pde 4 |
| 03/13/2003 | WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 03/13/2003 | WO2002040481A3 Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions and method of use thereof |
| 03/13/2003 | US20030050275 Partial and full agonists of A1 adenosine receptors |
| 03/13/2003 | US20030050229 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic |
| 03/13/2003 | CA2455896A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| 03/12/2003 | EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) |
| 03/12/2003 | EP1289561A2 Ligand conjugates and methods for preparing same |
| 03/12/2003 | EP1036058B1 Adamantane derivatives |
| 03/12/2003 | EP1019426B1 Novel a1 adenosine receptor agonists and antagonists |
| 03/12/2003 | CN1402729A Polycycloalkylpurines as adenosine receptor antagonists |
| 03/12/2003 | CN1402724A Thiazolidinedione derivs. as antidiabetic agents |
| 03/11/2003 | US6531600 Treatment and compounds |
| 03/06/2003 | WO2003018745A2 Method of screening for drug hypersensitivity reaction |
| 03/06/2003 | US20030045533 Phosphodiesterase 4 inhibitors |
| 03/05/2003 | EP1288215A1 Production method of famciclovir and production and crystallization method of intermediate therefor |
| 03/05/2003 | EP1287532A2 Method for producing ?18 f]fluoride ion |
| 03/05/2003 | EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/05/2003 | CN1400975A 嘌呤衍生物 Purine derivatives |
| 03/05/2003 | CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound |
| 03/04/2003 | US6528515 Beta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (beta -FTC) and penciclovir |
| 03/04/2003 | US6528494 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 02/27/2003 | WO2003016563A2 Novel molecular target for neurotoxicity |
| 02/27/2003 | WO2003016561A2 Method for the production of cna |
| 02/27/2003 | WO2003001881A3 Cell-based high-throughput screening methods |
| 02/27/2003 | US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 02/27/2003 | CA2457611A1 Novel molecular target for neurotoxicity |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | CN1399636A Adenosine receptor antagonists and methods of making and using the same |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |